Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Current use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other Vitamin K antagonists
On warfarin therapy or other vitamin K antagonists within  days of treatment initiation
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists within the last  days
concomitant use of warfarin or other Vitamin K antagonists
Concomitant use of anticoagulants including warfarin, other vitamin K antagonists, and enoxaparin
No use of warfarin or similar vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Patients requiring a treatment by oral vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other Vitamin K antagonists
Concurrent use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists (for patients who are discontinuing warfarin or other vitamin K antagonists, a wash-out period of  effective half-lives is required prior to st dose of ibrutinib)
Concomitant use of warfarin or other Vitamin K antagonists.
Concomitant use of warfarin or other vitamin K antagonists
Use of concomitant anticoagulation with warfarin or other vitamin K antagonists is prohibited, as is treatment with these agents in the  days prior to signing the ICD. The use of other anticoagulants (eg, heparins) and anti-platelet agents is allowed per investigator's discretion. Arm C only (CC- in combination with obinutuzumab):
Concurrent use of warfarin or other vitamin K antagonists
Concomitant use of warfarin or other vitamin K antagonists
EXCLUSION CRITERIA (PRIOR TO IBRUTINIB ADMINISTRATION): Requirement for anticoagulation with warfarin or other vitamin K antagonists (concomitant use of other anticoagulants is permitted)
